THCV May Help With Diabetes and Weight Management
A review of preclinical and early human evidence suggests THCV, a non-psychoactive cannabinoid, could help manage metabolic disorders by suppressing appetite and improving insulin sensitivity.
Quick Facts
What This Study Found
THCV acts as a CB1 receptor antagonist and partial CB2 agonist, which in preclinical studies translated to appetite suppression, improved insulin sensitivity, enhanced glucose uptake, and reduced fat accumulation. Preliminary human trials showed possible appetite and blood sugar modulation.
Key Numbers
Preclinical studies showed improved insulin signaling, reduced lipid accumulation, and appetite suppression. Preliminary human data suggest glycemic control effects.
How They Did This
Narrative review synthesizing preclinical (cell, animal) and preliminary human trial evidence on THCV's effects on metabolic health including obesity and type 2 diabetes.
Why This Research Matters
With obesity and diabetes rates climbing globally, a non-psychoactive cannabinoid that suppresses appetite and improves metabolic function could represent a novel therapeutic avenue.
The Bigger Picture
Most cannabis research focuses on THC and CBD. THCV represents the next wave of cannabinoid science, with a pharmacological profile almost opposite to THC when it comes to appetite and metabolism.
What This Study Doesn't Tell Us
Most evidence is preclinical. Human trial data is preliminary with small samples. Optimal dosing, long-term safety, and drug interactions remain unknown. THCV availability in current cannabis products is limited.
Questions This Raises
- ?Will larger human trials confirm THCV's metabolic benefits?
- ?Can THCV be produced at scale for therapeutic use?
- ?How does THCV interact with diabetes medications?
Trust & Context
- Key Stat:
- THCV suppresses appetite and improves insulin sensitivity in preclinical studies
- Evidence Grade:
- Primarily preclinical evidence with only preliminary human trial data. Larger clinical trials needed.
- Study Age:
- 2025 review capturing the latest THCV research.
- Original Title:
- The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management.
- Published In:
- AIMS neuroscience, 12(1), 32-43 (2025)
- Authors:
- Mendoza, Scott
- Database ID:
- RTHC-07118
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is THCV?
Tetrahydrocannabivarin (THCV) is a non-psychoactive cannabinoid found in cannabis that, unlike THC, tends to suppress appetite rather than stimulate it. It acts differently on cannabinoid receptors than THC.
Can THCV help with weight loss?
Preclinical studies show THCV suppresses appetite, reduces fat accumulation, and increases energy expenditure. Early human trials suggest similar effects, but large-scale clinical confirmation is still needed.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07118APA
Mendoza, Scott. (2025). The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management.. AIMS neuroscience, 12(1), 32-43. https://doi.org/10.3934/Neuroscience.2025003
MLA
Mendoza, Scott. "The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management.." AIMS neuroscience, 2025. https://doi.org/10.3934/Neuroscience.2025003
RethinkTHC
RethinkTHC Research Database. "The role of tetrahydrocannabivarin (THCV) in metabolic disor..." RTHC-07118. Retrieved from https://rethinkthc.com/research/mendoza-2025-the-role-of-tetrahydrocannabivarin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.